A Price Jump From Pennies to $20/Pill for the Same Drug
Drug pricing should be subject to stricter regulation
Stay updated with breaking news from Agepha Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug pricing should be subject to stricter regulation
COP-AF trial results showed no significant reduction in co-primary endpoints of clinically important AF or myocardial injury after noncardiac thoracic surgery, although there were positive trends.
Aspirin is typically given after PCI for acute coronary syndrome but can lead to major bleeding. Colchicine appears to be safer and may be equally efficacious, pilot data suggest.
Michael J. Blaha, MD, MPH, discusses his interpretation of the growing data detailing the role of inflammation as a driver of cardiovascular risk and how clinicians can identify patients who stand to benefit most from colchicine 0.5 mg tablets.
Americans pip Dutch to the post in heart medicine registration